ARTICLE | Company News
Kissei, BHV in deal for diabetes candidate
January 7, 2011 1:37 AM UTC
Kissei Pharmaceutical Co. Ltd. (Tokyo:4547) granted BHV Pharma Inc. (Research Triangle Park, N.C.) exclusive rights outside of Japan, Korea and Taiwan to develop and commercialize Remogliflozin etabon...